Market Place
Sourcing Support
Novavax Shareholder Challenges CEO Pay and Leadership
08 Apr 2026 //
BIOSPACE
Shah Capital Intends to Vote Against Novavax`s Board Nominees
08 Apr 2026 //
REUTERS
Novavax Boosts `Amplification Strategy` Through Sanofi, Pfizer
06 Apr 2026 //
FIERCE PHARMA
Novavax Appoints Dr. Robert Walker as Executive Vice President
30 Mar 2026 //
PR NEWSWIRE
Novavax To Release Q4 & Full Year 2025 Financial Results
19 Feb 2026 //
PR NEWSWIRE
Novavax Transfers U.S. Marketing Rights For Nuvaxovid
04 Nov 2025 //
PR NEWSWIRE
Novavax offloads HQ lease to AstraZeneca in $60M deal
23 Oct 2025 //
FIERCE PHARMA
Novavax Consolidates Sites, Cutting Costs in Alignment Strategy
22 Oct 2025 //
PR NEWSWIRE
Novavax Announces Progress On Sanofi Agreement
01 Oct 2025 //
PRESS RELEASE
Novavax to Participate in Cantor Global Healthcare Conference
03 Sep 2025 //
PR NEWSWIRE
Novavax Announces Debt Refinancing Strategy
21 Aug 2025 //
PR NEWSWIRE
Novavax`s Q2 2025 Financial Results Due August 6
30 Jul 2025 //
PR NEWSWIRE
Novavax sells Czech production plant to Novo Nordisk for $200M
04 Dec 2024 //
FIERCE PHARMA
Novavax To Host Q2 2024 Results Call On August 8
01 Aug 2024 //
PR NEWSWIRE
Zomedica Expand Truforma Addressable Market with Launch of Equine Cortisol Assay
27 Jun 2024 //
ACCESSWIRE
Novavax investor Shah Capital pushes for board shakeup
15 Apr 2024 //
REUTERS
Hedge fund Shah Capital recommends two new candidates for Novavax board
15 Apr 2024 //
REUTERS
Novavax to Participate in TD Cowen`s 44th Annual Health Care Conference
29 Feb 2024 //
PRESS RELEASE
After cuts, Novavax`s Q4 performance startles investors
28 Feb 2024 //
FIERCE PHARMA
Novavax to Host Conference to Discuss Q4 and Full Year 2023 Financial Results
20 Feb 2024 //
PR NEWSWIRE
Novavax announces fresh round of layoffs to rein in costs
01 Feb 2024 //
REUTERS
Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
PR NEWSWIRE
Novavax Makes Changes to Executive Leadership Team
17 Nov 2023 //
PR NEWSWIRE
Novavax to Participate in Jefferies London Healthcare Conference
10 Nov 2023 //
PR NEWSWIRE
Novavax plans for 2nd round of cuts, including more layoffs
09 Nov 2023 //
FIERCE BIOTECH
Novavax CCA and Advocacy Officer Appointed to Maryland Tech Council Board
27 Jul 2023 //
PRESS RELEASE
Novavax’s CEO promises a turnaround & how Lilly roiled the obesity market
29 Jun 2023 //
STAT NEWS
Novavax CEO says more cost cutting is on the way
13 Apr 2023 //
FIERCE BIOTECH
Novavax cut $50 million in costs, plans to slash more, CEO says
12 Apr 2023 //
REUTERS
Novavax to Participate in TD Cowen`s 43rd Annual Health Care Conference
06 Mar 2023 //
PR NEWSWIRE
Coronavirus (COVID-19) Current Therapy Global Market Report 2023
14 Feb 2023 //
PR NEWSWIRE
Could Novavax Stock Help You Become a Millionaire?
20 Jan 2023 //
FOOL
Novavax to Participate in the 41st Annual J.P. Morgan Healthcare Conference
09 Jan 2023 //
PRESS RELEASE
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination
30 Dec 2022 //
PR NEWSWIRE
Novavax Announces Closing of $175.25M Offering of Convertible Senior Notes
28 Dec 2022 //
PRESS RELEASE
German Health Authority Expands Recommendation for Use of Novavax as a Booster
16 Dec 2022 //
PRESS RELEASE
Novavax plans to raise $250M through stock, debt sales
15 Dec 2022 //
ENDPTS
Novavax Announces Pricing of $65 Million Public Offering of Common Stock
15 Dec 2022 //
PRNEWSWIRE
Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes
15 Dec 2022 //
PRNEWSWIRE
Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes
14 Dec 2022 //
PRESS RELEASE
Novavax Announces Proposed $125 Million Public Offering of Common Stock
14 Dec 2022 //
PRESS RELEASE
Health Authorities Expand Recommendations for Use of Nuvaxovid as a Booster
12 Dec 2022 //
PRESS RELEASE
Novavax to make COVID-19 vaccine shots in Canada
08 Dec 2022 //
REUTERS
Novavax to Participate in BofA Securities Virtual Biotech SMID Cap Conference
02 Dec 2022 //
PRESS RELEASE
WHO Updates Emergency Use Listing for Novavax Vaccine as a Primary Series
29 Nov 2022 //
PRESS RELEASE
Health Canada grants expanded authorisation for Novavax’s Covid-19 vaccine
21 Nov 2022 //
PHARMACEUTICAL-TECHNOLOGY
Novavax ends COVID vaccine sale agreement with Gavi
21 Nov 2022 //
REUTERS
Novavax spells out vaccine vision for COVID and beyond
19 Nov 2022 //
FIERCEPHARMA
Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada
18 Nov 2022 //
PRNEWSWIRE
Novavax`s COVID-19 booster has been approved for adults, Health Canada says
17 Nov 2022 //
Q107
Novavax to Participate in Jefferies London Healthcare Conference
14 Nov 2022 //
BARRONS
Novavax to Participate in Jefferies London Healthcare Conference
14 Nov 2022 //
PRESS RELEASE
Novavax Nuvaxovid COVID-19 Vaccine Authorized in the United Kingdom
09 Nov 2022 //
PRESS RELEASE
With vax uptake slow, Novavax adjusts revenue projection to $2B
09 Nov 2022 //
FIERCEPHARMA
Novavax cuts full-year revenue forecast again amid weak demand
09 Nov 2022 //
REUTERS
Novavax details trial results for omicron-targeting booster shots
09 Nov 2022 //
BIOPHARMADIVE
Novavax Reports Third Quarter 2022 Financial Results and Operational Highlights
08 Nov 2022 //
PRNEWSWIRE
Novavax to Host Conference Call to Discuss 3Q 2022 FYR
01 Nov 2022 //
PRNEWSWIRE
Novavax Appoints Rick Rodgers to Board of Directors
01 Nov 2022 //
BIOSPACE
Why Novavax Stock Rose 12.57% on Friday
27 Oct 2022 //
FOOL
